Telix Pharmaceuticals Limited
TLPPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $207 | $710 | $119 | $123 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $130 | $159 | $97 | $65 |
| Inventory | $35 | $38 | $31 | $17 |
| Other Curr. Assets | $26 | $11 | $8 | $20 |
| Total Curr. Assets | $398 | $919 | $255 | $225 |
| Property Plant & Equip (Net) | $74 | $54 | $38 | $30 |
| Goodwill | $186 | $107 | $118 | $5 |
| Intangibles | $398 | $309 | $0 | $105 |
| Long-Term Investments | $4 | $6 | $10 | $12 |
| Tax Assets | $76 | $47 | $37 | $20 |
| Other NC Assets | $54 | $75 | $288 | $1 |
| Total NC Assets | $792 | $598 | $491 | $173 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,190 | $1,516 | $746 | $398 |
| Liabilities | – | – | – | – |
| Payables | $52 | $69 | $22 | $33 |
| Short-Term Debt | $21 | $21 | $4 | $2 |
| Tax Payable | $52 | $49 | $34 | $12 |
| Deferred Revenue | $4 | $11 | $12 | $11 |
| Other Curr. Liab. | $170 | $181 | $186 | $101 |
| Total Curr. Liab. | $299 | $331 | $258 | $157 |
| LT Debt | $397 | $560 | $18 | $16 |
| Deferred Rev, NC | $1 | $3 | $7 | $12 |
| Deferred Tax Liab, NC | $39 | $9 | $10 | $4 |
| Other NC Liab. | $32 | $45 | $57 | $60 |
| Total NC Liab. | $469 | $617 | $84 | $92 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $34 | $11 | $10 | $8 |
| Total Liabilities | $768 | $948 | $342 | $249 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $597 | $587 | $446 |
| Retained Earnings | -$151 | -$213 | -$234 | -$264 |
| AOCI | $100 | $184 | $50 | -$34 |
| Other Equity | $473 | $0 | $0 | $0 |
| Total Equity | $422 | $568 | $404 | $149 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,190 | $1,516 | $746 | $398 |
| Net Debt | $211 | -$129 | -$97 | -$106 |